Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Essential Healthcare News.
R1 Announces Investment from Khosla Ventures as it Accelerates AI-Driven Healthcare Transformation
GlobeNewswire, Inc.
·
May 28, 2025
MURRAY, Utah, May 28, 2025 (GLOBE NEWSWIRE) -- R1, an industry leader in managing and intelligently automating healthcare revenue management with over 20 years of experience, today announced an investment from Khosla Ventures, a leading backer of...
Bristol Myers Squibb to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
Business Wire
·
May 28, 2025
Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Goldman Sachs 46th Annual Global Healthcare Conference on Wednesday, June 11, 2025. The company will take part in a fireside chat beginning at 10:00 a.m. ET....
Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results
GlobeNewswire, Inc.
·
May 28, 2025
MELBOURNE, Australia and NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company advancing combination drug therapies for high-impact indications, today announced that it has...
Calgary refugees have their healthcare services saved temporarily thanks to Calgary Health Foundation donors
GlobeNewswire, Inc.
·
May 28, 2025
Calgary, Alberta, Canada, May 28, 2025 (GLOBE NEWSWIRE) -- Calgary Health Foundation is proud to announce a commitment to the Calgary Refugee Health Clinic, one that will secure its operations for the next two years. The $550K promise, made...
Aclaris Therapeutics to Participate in Two June Healthcare Conferences
GlobeNewswire, Inc.
·
May 28, 2025
WAYNE, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company...
Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire, Inc.
·
May 28, 2025
REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at the...
Flare Therapeutics to Participate in Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced...
Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 28, 2025
SEATTLE and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a...
Astria Therapeutics to Present at Upcoming Jefferies Global Healthcare Conference
Business Wire
·
May 28, 2025
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will participate in a...
Scholar Rock to Present at the Jefferies Global Healthcare Conference
Business Wire
·
May 28, 2025
Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today announced...
Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 28, 2025
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, and...
Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025
GlobeNewswire, Inc.
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that Akebia Executive Management...
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
GlobeNewswire, Inc.
·
May 28, 2025
WEST CHESTER, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today...
Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 28, 2025
MORRISVILLE, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the company’s Chief Executive Officer Dr. Roger Jeffs, Chief Financial Officer and Chief Operating Officer Michael Kaseta, and Chief...
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference
GlobeNewswire, Inc.
·
May 28, 2025
ALACHUA, Fla. and TAMPA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Michael Dale, board...
Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 28, 2025
NEW YORK and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 agonists for the...
Solid Biosciences to Participate at the Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 28, 2025
CHARLESTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, announced that Bo Cumbo,...
Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025
GlobeNewswire, Inc.
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that its management team is...
Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 28, 2025
SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need,...
Monte Rosa Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
May 28, 2025
BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that Markus Warmuth, M.D., Chief...